Zoetis Inc. (ZTS)

97.95
0.02 0.02
NYSE : Health Technology
Prev Close 97.93
Open 97.42
Day Low/High 97.24 / 98.56
52 Wk Low/High 77.00 / 96.57
Volume 1.03M
Avg Volume 2.41M
Exchange NYSE
Shares Outstanding 478.77M
Market Cap 47.70B
EPS 3.00
P/E Ratio 34.01
Div & Yield 0.66 (0.55%)

Latest News

Institutional Selling, Europe's Economy, Nvidia Earnings Preview: Market Recon

Institutional Selling, Europe's Economy, Nvidia Earnings Preview: Market Recon

What trader has never both fallen in love with Nvidia, only to eventually feel the scorn of an angry lover's tortured vengeance?

Markets Are Headed For a More Difficult Environment: Market Recon

Markets Are Headed For a More Difficult Environment: Market Recon

Santa is on his way... A lot of pressure on the jolly fellow this year.

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

Zoetis Could Pull Back in the Short Run, but We Have Higher Price Targets Longer

Zoetis Could Pull Back in the Short Run, but We Have Higher Price Targets Longer

ZTS discovers, develops, manufactures, and markets veterinary vaccines and medicines.

Zoetis Surges to New Highs: Where to Buy It Now

Zoetis Surges to New Highs: Where to Buy It Now

Let's take the charts and indicators for a walk and see how high they may go in the weeks ahead.

Jim Cramer: 4 Pet-Related Stocks That Are Top Dog

Jim Cramer: 4 Pet-Related Stocks That Are Top Dog

The humanization of pets theme is driving outstanding earnings and share price growth for these 4 names.

2 Ways to Play Nvidia Into Earnings: Market Recon

2 Ways to Play Nvidia Into Earnings: Market Recon

Go long on strong fundamentals, or try this options strategy.

We Are Never Going Back to Easy Markets: Market Recon

We Are Never Going Back to Easy Markets: Market Recon

Consistency in discipline will make the difference.

Jim Cramer: Follow the Bouncing Equities

Jim Cramer: Follow the Bouncing Equities

Markets start day with a bungee jump.

Maybe This Is Not Really About Inflation -- Market Recon

Maybe This Is Not Really About Inflation -- Market Recon

Overreaction seems to be what markets are good at in this 'golden age of electronic trading.'

How to Play Eight Potential Breakout Stocks

How to Play Eight Potential Breakout Stocks

A partial list of names that are showing signs of breaking out Monday.

My Trader Side Prefers Jay Powell; My Economist Side Likes Rules: Market Recon

My Trader Side Prefers Jay Powell; My Economist Side Likes Rules: Market Recon

My economist side would clearly prefer a rules-based approach toward monetary policy.

These Stocks Have Changed Direction

These Stocks Have Changed Direction

Finding bullish and bearish reversals in the market.

Cramer: As Fed Moves to Tighten, Other Things Come Unraveled

Cramer: As Fed Moves to Tighten, Other Things Come Unraveled

The list begins with oil, but there's a ripple effect.

Animal Health Company Zoetis ZTS Reported Earnings Thursday

Animal Health Company Zoetis ZTS Reported Earnings Thursday

The company lowered guidance for FY 2017, which is likely to blame for the company's fall.

Bill Ackman Sells Zoetis, Holds Chipotle

Bill Ackman Sells Zoetis, Holds Chipotle

Ackman launched a winning activist campaign at Chipotle last year.

Use Pullback on Zoetis to Do Some Buying

Use Pullback on Zoetis to Do Some Buying

Prices are likely to go higher.

Cramer: Barking Up the Right Tree With Pet Health Stocks

Cramer: Barking Up the Right Tree With Pet Health Stocks

The Mars-VCA deal is yet another sign that pet health is a robust business.

Don't Ignore Agricultural ETFs

Don't Ignore Agricultural ETFs

One of them made an explosive move earlier this week.

Don't Ignore Agricultural ETFs

Don't Ignore Agricultural ETFs

One of them made an explosive move earlier this week.

Trending Tickers: ZTS, AGN, WFT, MRO

Trending Tickers: ZTS, AGN, WFT, MRO

Zoetis shares were climbing off an earnings beat and raised 2016 guidance.

Jim Cramer: Zoetis Is a Well Run Company

Jim Cramer: Zoetis Is a Well Run Company

Jim Cramer says Zoetis, an animal health company, is well run.

Cramer: These Themes Stand the Test of Turbulent Times

Cramer: These Themes Stand the Test of Turbulent Times

Teeth, pets, video games, eating at home are evidence of strong theses.

Bullish and Bearish Reversals for the Week

Bullish and Bearish Reversals for the Week

Here's a window into what institutional investors may be doing and how to profit from that.

Stressed Out: Valeant May Need $1.5B New Debt to Fill 'Capital Hole'

Stressed Out: Valeant May Need $1.5B New Debt to Fill 'Capital Hole'

It may not be possible for Valeant to wind down its massive debt as quickly as expected, say Deutsche Bank analysts.

Nervous Pooch? There's a Drug for That

Nervous Pooch? There's a Drug for That

Zoetis is not averse to a little noise as investors, analysts take notice.

Valeant Shares Rise on New CFO Appointment

Valeant Shares Rise on New CFO Appointment

Shares of Valeant Pharmaceuticals were higher Monday on news that the company named a new CFO.